Casado, José L <br/><br/>
Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART.  [electronic resource] 

 -  HIV clinical trials   
 - 1-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-4336 
<br/><br/><label>Standard No.: </label>10.1310/hct1401-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alkynes<br/>Anti-HIV Agents--therapeutic use<br/>Atazanavir Sulfate<br/>Benzoxazines--therapeutic use<br/>CD4 Lymphocyte Count<br/>Carbamates--therapeutic use<br/>Cohort Studies<br/>Cyclopropanes<br/>Darunavir<br/>Drug Therapy, Combination<br/>Female<br/>Furans<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--therapeutic use<br/>HIV-1--drug effects<br/>Humans<br/>Lipids--blood<br/>Lopinavir--therapeutic use<br/>Male<br/>Middle Aged<br/>Nitriles<br/>Oligopeptides--therapeutic use<br/>Organophosphates--therapeutic use<br/>Pyridazines--therapeutic use<br/>Pyridines--therapeutic use<br/>Pyrimidines<br/>Reverse Transcriptase Inhibitors--therapeutic use<br/>Ritonavir--therapeutic use<br/>Spain<br/>Sulfonamides--therapeutic use<br/>Treatment Outcome